Task: Answer the multiple-choice question.
Question: Which drug exhibits a 6.330% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a COC(=O)c1cc(C(=O)Nc2cc(C)ccn2)cc([N+](=O)[O-])c1
b CCN(CC(=O)Nc1c(F)cccc1F)C(=O)c1cccnc1SC
Answer: b. CCN(CC(=O)Nc1c(F)cccc1F)C(=O)c1cccnc1SC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC(=O)Nc1c(F)cccc1F)C(=O)c1cccnc1SC
CCN(CC(=O)Nc1c(F)cccc1F)C(=O)c1cccnc1SC
N-[2-(2,6-difluoroanilino)-2-oxoethyl]-N-ethyl-2-methylsulfanylpyridine-3-carboxamide